AAAAAA

   
Results: 1-15 |
Results: 15
HLA DQA1X0501 and DRB10301 antigens do not independently convey susceptibility to Graves' disease
Authors: Philippou, G Krimitzas, A Kaltsas, G Anastasiou, E Souvatzoglou, A Alevizaki, M
Citation: G. Philippou et al., HLA DQA1X0501 and DRB10301 antigens do not independently convey susceptibility to Graves' disease, J ENDOC INV, 24(2), 2001, pp. 88-91
The role of chemotherapy management of malignant in the nonsurgical neuroendocrine tumours
Authors: Kaltsas, G Mukherjee, JJ Plowman, PN Grossman, AB
Citation: G. Kaltsas et al., The role of chemotherapy management of malignant in the nonsurgical neuroendocrine tumours, CLIN ENDOCR, 55(5), 2001, pp. 575-587
Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply
Authors: Monson, JP Coyte, D Kaltsas, G Jenkins, PJ Chew, SL Grossman, AB Besser, GM
Citation: Jp. Monson et al., Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply, CLIN ENDOCR, 55(5), 2001, pp. 696-697
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors
Authors: Kaltsas, G Korbonits, M Heintz, E Mukherjee, JJ Jenkins, PJ Chew, SL Reznek, R Monson, JP Besser, GM Foley, R Britton, KE Grossman, AB
Citation: G. Kaltsas et al., Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors, J CLIN END, 86(2), 2001, pp. 895-902
Clinical case seminar - Pituitary chondrosarcoma: An unusual cause of a sellar mass presenting as a pituitary adenoma
Authors: Allan, CA Kaltsas, G Evanson, J Geddes, J Lowe, DG Plowman, PN Grossman, AB
Citation: Ca. Allan et al., Clinical case seminar - Pituitary chondrosarcoma: An unusual cause of a sellar mass presenting as a pituitary adenoma, J CLIN END, 86(1), 2001, pp. 386-391
Concurrent secretion of aldosterone and cortisol from an adrenal adenoma -value of MRI in diagnosis
Authors: Allan, CA Kaltsas, G Perry, L Lowe, DG Reznek, R Carmichael, D Monson, JP
Citation: Ca. Allan et al., Concurrent secretion of aldosterone and cortisol from an adrenal adenoma -value of MRI in diagnosis, CLIN ENDOCR, 53(6), 2000, pp. 749-753
Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two yearstudy
Authors: Florakis, D Hung, V Kaltsas, G Coyte, D Jenkins, PJ Chew, SL Grossman, AB Besser, GM Monson, JP
Citation: D. Florakis et al., Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two yearstudy, CLIN ENDOCR, 53(4), 2000, pp. 453-459
Porous silicon as an effective material for thermal isolation on bulk crystalline silicon
Authors: Nassiopoulou, AG Kaltsas, G
Citation: Ag. Nassiopoulou et G. Kaltsas, Porous silicon as an effective material for thermal isolation on bulk crystalline silicon, PHYS ST S-A, 182(1), 2000, pp. 307-311
Micro-Raman analysis of polysilicon membranes deposited on porous silicon channels
Authors: Talaat, H Negm, S Schaffer, HE Kaltsas, G Nassiopoulou, AG
Citation: H. Talaat et al., Micro-Raman analysis of polysilicon membranes deposited on porous silicon channels, J NON-CRYST, 266, 2000, pp. 1345-1349
Uterine leiomyomata in women with acromegaly
Authors: Kaltsas, G Jenkins, PJ Webb, J Monson, JP Besser, MG Grossman, A
Citation: G. Kaltsas et al., Uterine leiomyomata in women with acromegaly, J CLIN END, 85(3), 2000, pp. 1347-1347
Novel C-MOS compatible monolithic silicon gas flow sensor with porous silicon thermal isolation
Authors: Kaltsas, G Nassiopoulou, AG
Citation: G. Kaltsas et Ag. Nassiopoulou, Novel C-MOS compatible monolithic silicon gas flow sensor with porous silicon thermal isolation, SENS ACTU-A, 76(1-3), 1999, pp. 133-138
Hexarelin as a test of pituitary reserve in patients with pituitary disease
Authors: Korbonits, M Kaltsas, G Perry, LA Grossman, AB Monson, JP Besser, GM Trainer, PJ
Citation: M. Korbonits et al., Hexarelin as a test of pituitary reserve in patients with pituitary disease, CLIN ENDOCR, 51(3), 1999, pp. 369-375
The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin
Authors: Korbonits, M Kaltsas, G Perry, LA Putignano, P Grossman, AB Besser, GM Trainer, PJ
Citation: M. Korbonits et al., The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin, J CLIN END, 84(7), 1999, pp. 2489-2495
Modulation of 11 beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: In vivo and in vitro studies
Authors: Moore, JS Monson, JP Kaltsas, G Putignano, P Wood, PJ Sheppard, MC Besser, GM Taylor, NF Stewart, PM
Citation: Js. Moore et al., Modulation of 11 beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: In vivo and in vitro studies, J CLIN END, 84(11), 1999, pp. 4172-4177
Low expression of the cell cycle inhibitor p27(Kip1) in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors
Authors: Lidhar, K Korbonits, M Jordan, S Khalimova, Z Kaltsas, G Lu, X Clayton, RN Jenkins, PJ Monson, JP Besser, GM Lowe, DG Grossman, AB
Citation: K. Lidhar et al., Low expression of the cell cycle inhibitor p27(Kip1) in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors, J CLIN END, 84(10), 1999, pp. 3823-3830
Risultati: 1-15 |